EP1471960A1 — Devices and methods for nebulizing fluids for inhalation
Assigned to Novartis AG · Expires 2004-11-03 · 22y expired
What this patent protects
A nebulizer comprising an aerosol generator (100) and a titration mechanism (20) comprising a dosing mechanism (30), a screw assembly (50), a plunger (60) and an actuator (40), wherein the dosing mechanism is rotatably mounted in the nebulizer and the plunger is mounted in the ne…
USPTO Abstract
A nebulizer comprising an aerosol generator (100) and a titration mechanism (20) comprising a dosing mechanism (30), a screw assembly (50), a plunger (60) and an actuator (40), wherein the dosing mechanism is rotatably mounted in the nebulizer and the plunger is mounted in the nebulizer to travel along a longitudinal axis (62) substantially perpendicular to the plane of rotation of the dosing mechanism. The actuator is mounted to the nebulizer to travel in the direction (42) of the longitudinal axis. The screw mechanism allows the rotation of the dosing mechanism to fix a variable distance of travel of the plunger based on the selected dose, without moving the plunger longitudinally. This allows the user to verify and if necessary correct the selected dose prior to any drug being released from the vial. Operation of the actuator causes longitudinal movement, through the screw mechanism, to the plunger.
Drugs covered by this patent
- Cutivate (FLUTICASONE PROPIONATE) · Teva Pharm
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.